Novo Will Work With Anthropic AI to Speed Drug Development

Novo Nordisk is partnering with Anthropic to utilize artificial intelligence for accelerating the drug development process. The collaboration aims to strengthen the pharmaceutical company's research capabilities as it seeks to remain competitive in the rapidly expanding obesity treatment market.